Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Yinyin Yuan
Based on 13 articles published since 2009
(Why 13 articles?)
||||
Expertise Level
The expertise of Yinyin Yuan ranks in the
  • Top 1.8%
  • ... of 287,191 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 13 articles on the topic.
Graphical view (beta)
Work Locations
Details
Most likely:    University of London      
2018
  • The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Division of Molecular Pathology, Centre for Evolution and Cancer and Centre for Molecular Pathology, The Institute of Cancer Research, London, United Kingdom. · The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom. · Cancer Bioinformatics, Cancer Division, King's College London, London, United Kingdom. · Breast Cancer Now Research Unit, King's College London, London, United Kingdom. · Clinical Oncology, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, United Kingdom. · Department of Histopathology and Division of Cancer & Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, United Kingdom. · The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Pubmed 29133620
2016
  • Centre for Molecular Pathology, Institute of Cancer Research, London SM2 5NG, UK; Centre for Evolution and Cancer, Institute of Cancer Research, London SM2 5NG, UK; Division of Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UK. · Pubmed 26592351
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Centre for Molecular Pathology, Royal Marsden Hospital, London, UK. · Pubmed 27812028
  • Division of Cancer Biology, The Institute of Cancer Research, London, UK. · Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. · The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Pubmed 27556857
  • Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom. · Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom. · Division of Cancer Biology, The Institute of Cancer Research, London, United Kingdom. · Centre for Molecular Pathology, Royal Marsden Hospital, London, United Kingdom. · Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom. · Pubmed 26881778
  • Division of Cancer Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK. Cancer Research UK Manchester Institute, The University of Manchester, Wilmslow Road, Manchester M20 4BX, UK. · Division of Cancer Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK. · Cancer Research UK Manchester Institute, The University of Manchester, Wilmslow Road, Manchester M20 4BX, UK. · The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. · Centre for Evolution and Cancer and Centre for Molecular Pathology, Division of Molecular Pathology, The Institute of Cancer Research, 15 Cotswold Road, Sutton SM2 5NG, UK. · Division of Cancer Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK. Cancer Research UK Manchester Institute, The University of Manchester, Wilmslow Road, Manchester M20 4BX, UK. · Pubmed 26861043
2015
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Center for Evolution and Cancer, University of California San Francisco, San Francisco, CA, USA. · Biodesign Institute, School of Life Sciences, Arizona State University, Tempe, AZ, USA. · Division of Breast Cancer, The Institute of Cancer Research, London, UK. · Department of Histopathology, The Royal Marsden Hospital, London, UK. · Division of Breast Cancer, The Institute of Cancer Research, London, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Center for Evolution and Cancer, University of California San Francisco, San Francisco, CA, USA. · Department of Psychology, Arizona State University, Tempe, AZ, USA. · Center for Evolution and Medicine, Biodesign Institute, Arizona State University, AZ, USA. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Centre for Molecular Pathology, The Royal Marsden Hospital, London, UK. · Pubmed 26395345
  • 1] Division of Molecular Pathology, The Institute of Cancer Research, London, UK [2] Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK [3] Centre for Molecular Pathology, Royal Marsden Hospital, London, UK. · 1] Functional Genomics Laboratory, Institute of Cancer Research, London, UK [2] Department of Histopathology, The Royal Marsden Hospital, London, UK. · Pubmed 25720324
  • Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK. · Division of Molecular Pathology, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK. · Division of Molecular Pathology, Haemato-Oncology Research Unit, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK. · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. · Nuclear Dynamics Programme, The Babraham Institute, Cambridge CB22 3AT, UK. · Department of Biosciences and Nutrition, Science for Life Laboratory, Karolinska Institutet, 14 183, Huddinge, Sweden. · Pubmed 25695508
  • Division of Molecular Pathology, Centre for Evolution and Cancer and Centre for Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UK · Pubmed 25505134
  • Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Department of Oncology, Division for Surgery, Cancer and Transplantation, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. · Department of Pathology and Laboratory Medicine, University of British Colombia, Vancouver, British Colombia V6T 2B5, Canada; Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. · The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Biomedical Informatics Division, Department of Computer Science, University of Oslo, Oslo, Norway; Center for Cancer Biomedicine, University of Oslo, Norway. · Division of Molecular Pathology, The Institute of Cancer Research, 237 Fulham Road, SW3 6JB, London, UK. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 9RN, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. · Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham, NG5 1PB, UK. · King's College London, Breakthrough Breast Cancer Research Unit, London WC2R 2LS, UK; NIHR Comprehensive Biomedical Research Centre at Guy's and St. Thomas NHS Foundation Trust and King's College London, London WC2R 2LS, UK. · Manitoba Institute of Cell Biology, CancerCare Manitoba, University of Manitoba, Manitoba R3E 0V9, Canada. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Department of Clinical Molecular Biology (EpiGen), Medical Division, Akershus University Hospital, Lørenskog, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 9RN, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway. · Department of Pathology and Laboratory Medicine, University of British Colombia, Vancouver, British Colombia V6T 2B5, Canada; Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. Electronic address: · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. Electronic address: · Pubmed 25169931
2012
  • Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK. · Pubmed 23100629
2018
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK; Centre for Molecular Pathology, Royal Marsden Hospital, London, UK; Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK; The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, UK; Cellular Pathology, Guy's and St Thomas' NHS Trust, Westminster Bridge Rd, London, UK; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, UK. · Pubmed 28859291
Probable:    Royal Marsden Hospital and Trust      
2016
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Centre for Molecular Pathology, Royal Marsden Hospital, London, UK. · Pubmed 27812028
  • Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom. · Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom. · Division of Cancer Biology, The Institute of Cancer Research, London, United Kingdom. · Centre for Molecular Pathology, Royal Marsden Hospital, London, United Kingdom. · Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom. · Pubmed 26881778
2015
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Center for Evolution and Cancer, University of California San Francisco, San Francisco, CA, USA. · Biodesign Institute, School of Life Sciences, Arizona State University, Tempe, AZ, USA. · Division of Breast Cancer, The Institute of Cancer Research, London, UK. · Department of Histopathology, The Royal Marsden Hospital, London, UK. · Division of Breast Cancer, The Institute of Cancer Research, London, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Center for Evolution and Cancer, University of California San Francisco, San Francisco, CA, USA. · Department of Psychology, Arizona State University, Tempe, AZ, USA. · Center for Evolution and Medicine, Biodesign Institute, Arizona State University, AZ, USA. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Centre for Molecular Pathology, The Royal Marsden Hospital, London, UK. · Pubmed 26395345
  • 1] Division of Molecular Pathology, The Institute of Cancer Research, London, UK [2] Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK [3] Centre for Molecular Pathology, Royal Marsden Hospital, London, UK. · 1] Functional Genomics Laboratory, Institute of Cancer Research, London, UK [2] Department of Histopathology, The Royal Marsden Hospital, London, UK. · Pubmed 25720324
2018
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK; Centre for Molecular Pathology, Royal Marsden Hospital, London, UK; Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK; The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, UK; Cellular Pathology, Guy's and St Thomas' NHS Trust, Westminster Bridge Rd, London, UK; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, UK. · Pubmed 28859291
Possible:    Guy's and St Thomas' NHS Trust      
2018
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK; Centre for Molecular Pathology, Royal Marsden Hospital, London, UK; Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK; The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, UK; Cellular Pathology, Guy's and St Thomas' NHS Trust, Westminster Bridge Rd, London, UK; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, UK. · Pubmed 28859291
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 13 total) written by Yinyin Yuan about Breast Neoplasms:

  • Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer. 2018
  • Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer. 2018
  • Computational pathology: Exploring the spatial dimension of tumor ecology. 2016
  • Biopsy variability of lymphocytic infiltration in breast cancer subtypes and the ImmunoSkew score. 2016
  • Systematic analysis of tumour cell-extracellular matrix adhesion identifies independent prognostic factors in breast cancer. 2016
  • Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology-Genomic Integration Analysis. 2016
  • Phosphoproteomic analysis of interacting tumor and endothelial cells identifies regulatory mechanisms of transendothelial migration. 2016
  • An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer. 2015
  • Beyond immune density: critical role of spatial heterogeneity in estrogen receptor-negative breast cancer. 2015
  • Capture Hi-C identifies the chromatin interactome of colorectal cancer risk loci. 2015
Show List of Full Article Records
Google Searches

Learn more about Yinyin Yuan using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of London
Royal Marsden Hospital and Trust
Guy's and St Thomas' NHS Trust
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of London
2018
  • The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Division of Molecular Pathology, Centre for Evolution and Cancer and Centre for Molecular Pathology, The Institute of Cancer Research, London, United Kingdom. · The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom. · Cancer Bioinformatics, Cancer Division, King's College London, London, United Kingdom. · Breast Cancer Now Research Unit, King's College London, London, United Kingdom. · Clinical Oncology, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, United Kingdom. · Department of Histopathology and Division of Cancer & Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, United Kingdom. · The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Pubmed 29133620
2016
  • Centre for Molecular Pathology, Institute of Cancer Research, London SM2 5NG, UK; Centre for Evolution and Cancer, Institute of Cancer Research, London SM2 5NG, UK; Division of Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UK. · Pubmed 26592351
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Centre for Molecular Pathology, Royal Marsden Hospital, London, UK. · Pubmed 27812028
  • Division of Cancer Biology, The Institute of Cancer Research, London, UK. · Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. · The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Pubmed 27556857
  • Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom. · Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom. · Division of Cancer Biology, The Institute of Cancer Research, London, United Kingdom. · Centre for Molecular Pathology, Royal Marsden Hospital, London, United Kingdom. · Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom. · Pubmed 26881778
  • Division of Cancer Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK. Cancer Research UK Manchester Institute, The University of Manchester, Wilmslow Road, Manchester M20 4BX, UK. · Division of Cancer Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK. · Cancer Research UK Manchester Institute, The University of Manchester, Wilmslow Road, Manchester M20 4BX, UK. · The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. · Centre for Evolution and Cancer and Centre for Molecular Pathology, Division of Molecular Pathology, The Institute of Cancer Research, 15 Cotswold Road, Sutton SM2 5NG, UK. · Division of Cancer Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK. Cancer Research UK Manchester Institute, The University of Manchester, Wilmslow Road, Manchester M20 4BX, UK. · Pubmed 26861043
2015
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Center for Evolution and Cancer, University of California San Francisco, San Francisco, CA, USA. · Biodesign Institute, School of Life Sciences, Arizona State University, Tempe, AZ, USA. · Division of Breast Cancer, The Institute of Cancer Research, London, UK. · Department of Histopathology, The Royal Marsden Hospital, London, UK. · Division of Breast Cancer, The Institute of Cancer Research, London, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Center for Evolution and Cancer, University of California San Francisco, San Francisco, CA, USA. · Department of Psychology, Arizona State University, Tempe, AZ, USA. · Center for Evolution and Medicine, Biodesign Institute, Arizona State University, AZ, USA. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Centre for Molecular Pathology, The Royal Marsden Hospital, London, UK. · Pubmed 26395345
  • 1] Division of Molecular Pathology, The Institute of Cancer Research, London, UK [2] Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK [3] Centre for Molecular Pathology, Royal Marsden Hospital, London, UK. · 1] Functional Genomics Laboratory, Institute of Cancer Research, London, UK [2] Department of Histopathology, The Royal Marsden Hospital, London, UK. · Pubmed 25720324
  • Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK. · Division of Molecular Pathology, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK. · Division of Molecular Pathology, Haemato-Oncology Research Unit, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK. · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. · Nuclear Dynamics Programme, The Babraham Institute, Cambridge CB22 3AT, UK. · Department of Biosciences and Nutrition, Science for Life Laboratory, Karolinska Institutet, 14 183, Huddinge, Sweden. · Pubmed 25695508
  • Division of Molecular Pathology, Centre for Evolution and Cancer and Centre for Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UK · Pubmed 25505134
  • Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Department of Oncology, Division for Surgery, Cancer and Transplantation, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. · Department of Pathology and Laboratory Medicine, University of British Colombia, Vancouver, British Colombia V6T 2B5, Canada; Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. · The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Biomedical Informatics Division, Department of Computer Science, University of Oslo, Oslo, Norway; Center for Cancer Biomedicine, University of Oslo, Norway. · Division of Molecular Pathology, The Institute of Cancer Research, 237 Fulham Road, SW3 6JB, London, UK. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 9RN, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. · Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham, NG5 1PB, UK. · King's College London, Breakthrough Breast Cancer Research Unit, London WC2R 2LS, UK; NIHR Comprehensive Biomedical Research Centre at Guy's and St. Thomas NHS Foundation Trust and King's College London, London WC2R 2LS, UK. · Manitoba Institute of Cell Biology, CancerCare Manitoba, University of Manitoba, Manitoba R3E 0V9, Canada. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Department of Clinical Molecular Biology (EpiGen), Medical Division, Akershus University Hospital, Lørenskog, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 9RN, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway. · Department of Pathology and Laboratory Medicine, University of British Colombia, Vancouver, British Colombia V6T 2B5, Canada; Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. Electronic address: · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. Electronic address: · Pubmed 25169931
2012
  • Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK. · Pubmed 23100629
2018
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK; Centre for Molecular Pathology, Royal Marsden Hospital, London, UK; Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK; The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, UK; Cellular Pathology, Guy's and St Thomas' NHS Trust, Westminster Bridge Rd, London, UK; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, UK. · Pubmed 28859291
Royal Marsden Hospital and Trust
2016
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Centre for Molecular Pathology, Royal Marsden Hospital, London, UK. · Pubmed 27812028
  • Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom. · Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom. · Division of Cancer Biology, The Institute of Cancer Research, London, United Kingdom. · Centre for Molecular Pathology, Royal Marsden Hospital, London, United Kingdom. · Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom. · Pubmed 26881778
2015
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Center for Evolution and Cancer, University of California San Francisco, San Francisco, CA, USA. · Biodesign Institute, School of Life Sciences, Arizona State University, Tempe, AZ, USA. · Division of Breast Cancer, The Institute of Cancer Research, London, UK. · Department of Histopathology, The Royal Marsden Hospital, London, UK. · Division of Breast Cancer, The Institute of Cancer Research, London, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Center for Evolution and Cancer, University of California San Francisco, San Francisco, CA, USA. · Department of Psychology, Arizona State University, Tempe, AZ, USA. · Center for Evolution and Medicine, Biodesign Institute, Arizona State University, AZ, USA. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Centre for Molecular Pathology, The Royal Marsden Hospital, London, UK. · Pubmed 26395345
  • 1] Division of Molecular Pathology, The Institute of Cancer Research, London, UK [2] Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK [3] Centre for Molecular Pathology, Royal Marsden Hospital, London, UK. · 1] Functional Genomics Laboratory, Institute of Cancer Research, London, UK [2] Department of Histopathology, The Royal Marsden Hospital, London, UK. · Pubmed 25720324
2018
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK; Centre for Molecular Pathology, Royal Marsden Hospital, London, UK; Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK; The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, UK; Cellular Pathology, Guy's and St Thomas' NHS Trust, Westminster Bridge Rd, London, UK; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, UK. · Pubmed 28859291
Guy's and St Thomas' NHS Trust
2018
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK; Centre for Molecular Pathology, Royal Marsden Hospital, London, UK; Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK; The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, UK; Cellular Pathology, Guy's and St Thomas' NHS Trust, Westminster Bridge Rd, London, UK; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, UK. · Pubmed 28859291
Barts Health NHS Trust
2018
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK; Centre for Molecular Pathology, Royal Marsden Hospital, London, UK; Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK; The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, UK; Cellular Pathology, Guy's and St Thomas' NHS Trust, Westminster Bridge Rd, London, UK; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, UK. · Pubmed 28859291
Yearly article counts 02055001000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.